Approval · Notice of Compliance 38411 · 2026
PMS-DICLOFENAC: Notice of Compliance 38411
Issued October 6, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38411
- Date
- October 6, 2026
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with CRP approved PM). Product Monograph reformatted to the Master Template
- Canadian reference product
- VOLTAREN (Novartis Pharmaceuticals Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-DICLOFENAC | Not yet assigned | — |
Medicinal ingredients
- DICLOFENAC SODIUM 25 MG per TAB
- DICLOFENAC SODIUM 50 MG per TAB